Skip to main content
AstraZeneca ditches plan for Gilead merger amid industry skepticism: report - FiercePharma 10-Jun-2020
AstraZeneca ditches plan for Gilead merger amid industry skepticism: report - FiercePharma
The excitement over a potential record-setting megamerger between AstraZeneca and Gilead Sciences looks short-lived. The British pharma has already ditched its interest in a marriage with the U.S. firm to focus on its own pipeline and COVID-19 vaccine efforts…
More...